Streetbeat News

Equity Actions

BZFD

BuzzFeed announced a 1-for-4 reverse stock split, leading to its shares trading lower.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:36 pm

BZFD

BuzzFeed, Inc. (NASDAQ:BZFD) announced a 1-for-4 reverse stock split effective May 6, 2024, to meet Nasdaq's minimum bid price requirement and ensure continued listing. The split will adjust the number of Class A and B common stock shares, aiming to increase the bid price above $1.00. The total authorized shares remain unchanged, and no fractional shares will be issued, with stockholders receiving whole shares instead.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:31 pm

OLB

OLB Group shares are trading higher after the company announced its shareholders approved a 1-for-10 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:24 pm

OLB

OLB Group has announced that its shareholders have approved a reverse stock split on a 1-for-10 basis. This means for every ten shares of OLB Group's common stock currently held, shareholders will now own one share.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 3:17 pm

SYY

Sysco (NYSE:SYY) was analyzed by four analysts, showing a mix of bullish to indifferent ratings. The average 12-month price target is now $85.00, down from $87.50. Analyst actions included both downgrades and an upgrade, with price targets adjusted accordingly. Sysco's financial performance shows strong revenue growth, net margin, ROE, and ROA, but a high debt-to-equity ratio. The company is a major player in the U.S. foodservice distribution market.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:01 pm

REGN

The analysis compares Regeneron Pharmaceuticals (REGN) against its competitors in the Biotechnology industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Regeneron shows potential undervaluation based on its P/E, P/B, and P/S ratios compared to industry averages. However, its ROE is below the industry average, suggesting inefficiency in using equity to generate profits. Despite this, Regeneron's EBITDA and gross profit are above the industry average, indicating strong operational performance. The company's revenue growth is significantly lower than the industry average, highlighting a challenging sales environment.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:00 pm

CDW

Recent analyst ratings for CDW (NASDAQ:CDW) show a mix of bullish to indifferent views, with an updated 12-month price target average of $272.5, reflecting an 8.64% increase from the previous target. Analyst actions include both raises and lowers in ratings and price targets, indicating varied perceptions of CDW's market position. Financially, CDW faces revenue challenges with a -7.72% decline over 3 months but maintains strong profitability indicators such as a net margin of 5.9%, ROE of 15.37%, and ROA of 2.26%, despite a high debt-to-equity ratio of 2.84.

Portfolio Pulse from Benzinga Insights

May 02, 2024 | 3:00 pm

BWA

BorgWarner's stock price increased following the announcement of stronger than anticipated Q1 financial results and an upward revision of its FY24 adjusted EPS guidance. Additionally, the company has initiated a new share repurchase program valued at up to $500 million.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 2:48 pm

LL

F9 Investments, LLC has reported an 8.8% stake in LL Flooring Holdings as of May 2, 2024, according to a 13D filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

May 02, 2024 | 2:45 pm

BABA

Alibaba Group Holding has seen significant options activity, with a notable transaction involving June 21 $85 call options, purchased at the ask price of $2.00 for a quantity of 250, against an open interest of 29,723. This activity comes ahead of Alibaba's earnings report, scheduled for May 14 before the market opens, with the reference stock price at $78.25.

Portfolio Pulse from Charles Gross

May 02, 2024 | 2:26 pm